Colitis
45
8
9
22
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
6.7%
3 terminated out of 45 trials
88.0%
+1.5% vs benchmark
11%
5 trials in Phase 3/4
32%
7 of 22 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 22 completed trials
Clinical Trials (45)
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
A Real-World Study of Guselkumab in Ulcerative Colitis and Crohn's Disease in Saudi Arabia
KAN-004 for Immune-Related Diarrhea or Colitis
Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
A Pilot Study Testing the Safety and Feasibility of Restorative Microbiota Therapy (RMT) in Patients With Refractory Immune-checkpoint Inhibitor-related Colitis
Optoacoustic Detection of Inflammation Using MSOT Device
Infliximab or Vedolizumab in Treating Immune Checkpoint Inhibitor-Related Colitis in Patients With Genitourinary Cancer or Melanoma
FMT in Checkpoint Inhibitor-mediated Diarrhea and Colitis
Improving Outcomes and Reducing Disparities for Patients With Inflammatory Bowel Disease Through Epidemiology and Enhanced Disease Management
Evaluate the Efficacy and Safety of Probiotic 6600 as an Adjuvant Therapy for Colitis
Intestinal Microbiome and Chronic Inflammatory Bowel Disease
A Study to Evaluate the Safety and Efficacy of Ustekinumab Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease (IM-UNITI)
Identification of Predictive Parameters for Colitis in Melanoma Patients Treated With Immunotherapy.
Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative Colitis
Intestinal Biomarker Analysis After ECP for ICI Colitis
Improved and Simplified Staining Technique for Dysplasia Detection in Colitis
PediCRaFT: Pediatric Crohn's Disease Fecal Transplant Trial
Study to Identify Non-Invasive Markers of Gastrointestinal Allergy
Efficacy and Safety of Infliximab for Immune Checkpoint Inhibitor Induced Colitis